Zivo Bioscience, Inc. (ZIVOW)
NCM
Closing price as of 2026-06-01 · Source: TEK2day Finance
Key Metrics
About Zivo Bioscience, Inc.
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.
Quarterly Financials
| Metric | 2024-12-31 | 2025-03-31 | 2025-06-30 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | 90K | 0.00 | 53K | 66K |
| Gross Profit | 27K | 0.00 | 18K | 21K |
| Operating Income | -1.6M | -4.2M | -1.6M | -1.0M |
| Net Income | -1.6M | -4.2M | -1.6M | -1.0M |
Annual Financials
| Metric | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 28K | 157K |
| Gross Profit | 0.00 | 12K | 49K | |
| Operating Income | -8.6M | -8.7M | -7.3M | -13.4M |
| Net Income | -8.8M | -8.7M | -7.8M | -13.4M |